Mark W Kunkel

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Metastatic Colorectal Cancer

Palliative Care

Top Venues

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research (2024)
Mark W Kunkel, Nathan P Coussens, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Eric M Jones, James H Doroshow, Beverly A Teicher
HTS384 NCI60: The Next Phase of the NCI60 Screen. Cancer research 84 (15) (2024)
Joel Morris, Mark W Kunkel, Stephen L White, Donn G Wishka, Omar D Lopez, Lori Bowles, Penny Sellers Brady, Patricia Ramsey, Julie Grams, Tiffany Rohrer, Karen Martin, Thomas S Dexheimer, Nathan P Coussens, David M Evans, Prabhakar Risbood, Dmitriy Sonkin, John D Williams, Eric C Polley, Jerry M Collins, James H Doroshow, Beverly A Teicher
Targeted Investigational Oncology Agents (IOA) in the NCI60: A Phenotypic Systems-Based Resource. Molecular cancer therapeutics (2023)